Completed PHASE4 INTERVENTIONAL 2-arm NCT01178671

Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial

Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD)

Sponsor: National Institute of Mental Health (NIMH)

Conditions Posttraumatic Stress Disorder

Interventions Mirtazapine Sertraline Sugar pill

Updated 7 times since 2017 Last updated: Apr 2, 2016 Started: Jul 31, 2010 Primary completion: May 31, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Posttraumatic Stress Disorder, this trial is completed. The trial is conducted by National Institute of Mental Health (NIMH) and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
Research Foundation for Mental Hygiene, Inc.

Data source: Research Foundation for Mental Hygiene, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States